DAYPRO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Daypro, and when can generic versions of Daypro launch?
Daypro is a drug marketed by Pfizer and is included in two NDAs.
The generic ingredient in DAYPRO is oxaprozin potassium. There are thirteen drug master file entries for this compound. Additional details are available on the oxaprozin potassium profile page.
Summary for DAYPRO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,446 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for DAYPRO |
| What excipients (inactive ingredients) are in DAYPRO? | DAYPRO excipients list |
| DailyMed Link: | DAYPRO at DailyMed |
Recent Clinical Trials for DAYPRO
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sanford Research | Early Phase 1 |
Pharmacology for DAYPRO
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for DAYPRO
US Patents and Regulatory Information for DAYPRO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | DAYPRO | oxaprozin | TABLET;ORAL | 018841-004 | Oct 29, 1992 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Pfizer | DAYPRO ALTA | oxaprozin potassium | TABLET;ORAL | 020776-001 | Oct 17, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
